SCHEMBL8937488

SCHEMBL8937488

COc1ccc(/C(=C\C(=O)O)c2cccc(F)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.60
KDM4E B2RXH2 1/20 0.60
GAA P10253 2/20 0.55
LMNA P02545 1/20 0.55
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
CES2 O00748 2/20 0.47
CES1 P23141 2/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
POLB P06746 1/20 0.47
RELA Q04206 1/20 0.46
NFE2L2 Q16236 1/20 0.46
KCNK9 Q9NPC2 1/20 0.45
TP53 P04637 1/20 0.44
MAPT P10636 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8937486 1.00 ALDH1A1 (0.60) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL8937491 1.00 ALDH1A1 (0.60) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL15199301 0.89 ALDH1A1 (0.60) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL8937240 0.87 CA1 (0.47) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL8937231 0.87 CA1 (0.47) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL8937237 0.87 CA1 (0.47) ALDH1A1KDM4EGAALMNANPC1
SCHEMBL8937402 0.85 LMNA (0.57) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL8937407 0.85 LMNA (0.57) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL8937405 0.85 LMNA (0.57) ALDH1A1KDM4ELMNANPC1RAB9A
SCHEMBL6561899 0.85 ALDH1A1 (0.60) ALDH1A1KDM4EGAALMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
US-5556852-A PLATELET ACTIVATING FACTOR ANTAGONISTS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed